CY1113999T1 - Σταθερο ετοιμο προς χρηση ενεσιμο σκευασμα παρακεταμολης - Google Patents
Σταθερο ετοιμο προς χρηση ενεσιμο σκευασμα παρακεταμοληςInfo
- Publication number
- CY1113999T1 CY1113999T1 CY20131100241T CY131100241T CY1113999T1 CY 1113999 T1 CY1113999 T1 CY 1113999T1 CY 20131100241 T CY20131100241 T CY 20131100241T CY 131100241 T CY131100241 T CY 131100241T CY 1113999 T1 CY1113999 T1 CY 1113999T1
- Authority
- CY
- Cyprus
- Prior art keywords
- paraketamol
- administration
- stable prepared
- stabilizing
- paracetamol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η εφεύρεση αφορά ένα σταθερό υδατικό διάλυμα παρακεταμόλης προς χρήση σε ενδοφλέβια (i.v.) έγχυση περιέχον τουλάχιστον μία σταθεροποιητική-διαλυτοποιητική ένωση για παρακεταμόλη σε διάλυμα που επιλέγεται από την ομάδα που περιλαμβάνει κυκλοδεξτρίνες, τουλάχιστον μία σταθεροποιητική ένωση που φέρει τουλάχιστον μία δραστική ομάδα θειόλης και τουλάχιστον μία σταθεροποιητική ένωση που επιλέγεται από την ομάδα που περιλαμβάνει άλατα Θειαμίνης.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10005258A EP2389923B1 (en) | 2010-05-19 | 2010-05-19 | Stable ready to use injectable paracetamol formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1113999T1 true CY1113999T1 (el) | 2016-07-27 |
Family
ID=42338244
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20131100241T CY1113999T1 (el) | 2010-05-19 | 2013-03-22 | Σταθερο ετοιμο προς χρηση ενεσιμο σκευασμα παρακεταμολης |
Country Status (22)
Country | Link |
---|---|
US (1) | US8877817B2 (el) |
EP (1) | EP2389923B1 (el) |
CN (1) | CN102985069B (el) |
AP (1) | AP3151A (el) |
BR (1) | BR112012029212A2 (el) |
CA (1) | CA2799666C (el) |
CY (1) | CY1113999T1 (el) |
DK (1) | DK2389923T3 (el) |
ES (1) | ES2403121T3 (el) |
HK (1) | HK1182315A1 (el) |
HR (1) | HRP20130184T1 (el) |
MA (1) | MA34314B1 (el) |
MY (1) | MY160458A (el) |
PL (1) | PL2389923T3 (el) |
PT (1) | PT2389923E (el) |
RU (1) | RU2519764C1 (el) |
SI (1) | SI2389923T1 (el) |
SM (1) | SMT201300038B (el) |
TN (1) | TN2012000516A1 (el) |
UA (1) | UA104381C2 (el) |
WO (1) | WO2011144335A1 (el) |
ZA (1) | ZA201208605B (el) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA201300398B (en) * | 2012-11-27 | 2013-09-25 | Genfarma Laboratories S L | Injectable liquid formulation of the combination of tramadol and paracetamol |
WO2016008546A1 (en) * | 2014-07-18 | 2016-01-21 | Everbright Pharmaceuticals S.A.R.L. | Aqueous formulation comprising paracetamol and ibuprofen |
CN105797166A (zh) * | 2016-03-30 | 2016-07-27 | 吉林长白山药业集团股份有限公司 | 用羟丙基环糊精包合对乙酰氨基酚制成液体制剂的方法 |
WO2018192664A1 (en) | 2017-04-20 | 2018-10-25 | Hyloris Developments Sa | METHOD FOR PREPARING A COMPOSITION WITH A LOW DISSOLVED OXYGEN CONTENT, COMPRISING ACETAMINOPHEN, AND OPTIONALLY ONE OR MORE NSAIDs, AND A COMPOSITION OBTAINED THEREOF |
WO2019180072A1 (en) | 2018-03-22 | 2019-09-26 | Bayer Pharma Aktiengesellschaft | Parenteral pharmaceutical composition comprising neladenoson bialanate |
WO2021222835A1 (en) * | 2020-04-30 | 2021-11-04 | Purser Danny C | Compositions and methods comprising stable reduced glutathione |
GR1010637B (el) * | 2023-01-13 | 2024-02-15 | Ιουλια Κλεωνος Τσετη | Σταθερο υδατικο διαλυμα παρακεταμολης για χρηση σε ενδοφλεβια εγχυση |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH648371A5 (de) | 1982-01-29 | 1985-03-15 | Fischer Ag Georg | Anschlusseinrichtung fuer armaturen. |
US4727064A (en) | 1984-04-25 | 1988-02-23 | The United States Of America As Represented By The Department Of Health And Human Services | Pharmaceutical preparations containing cyclodextrin derivatives |
FR2751875B1 (fr) | 1996-08-05 | 1998-12-24 | Scr Newpharm | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation |
JP2001233787A (ja) * | 2000-02-04 | 2001-08-28 | Patents Exploitation Co Bv | 小・中サイズのペプチド含有薬学的組成物 |
US20040045546A1 (en) * | 2002-09-05 | 2004-03-11 | Peirce Management, Llc | Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use |
FR2851164B1 (fr) * | 2003-02-14 | 2005-04-22 | Xuan Tho Nguyen | Formulation liquide injectable de paracetamol |
US9399012B2 (en) * | 2007-11-13 | 2016-07-26 | Mallinckrodt Ip | Reduced dose intravenous acetaminophen |
EP2307056B1 (en) * | 2008-01-17 | 2021-12-15 | Pharmis Biofarmacêutica, LDA | Stabilized aqueous formulation containing paracetamol |
US20090246276A1 (en) * | 2008-01-28 | 2009-10-01 | Graham Jackson | Pharmaceutical Compositions |
CN102488716B (zh) * | 2008-02-29 | 2013-09-11 | 株式会社明治 | 丙酸杆菌发酵物在制造皮肤粗糙预防、改善剂中的应用 |
-
2010
- 2010-05-19 ES ES10005258T patent/ES2403121T3/es active Active
- 2010-05-19 SI SI201030168T patent/SI2389923T1/sl unknown
- 2010-05-19 PT PT100052588T patent/PT2389923E/pt unknown
- 2010-05-19 DK DK10005258.8T patent/DK2389923T3/da active
- 2010-05-19 PL PL10005258T patent/PL2389923T3/pl unknown
- 2010-05-19 EP EP10005258A patent/EP2389923B1/en active Active
-
2011
- 2011-05-18 RU RU2012151433/15A patent/RU2519764C1/ru active
- 2011-05-18 WO PCT/EP2011/002482 patent/WO2011144335A1/en active Application Filing
- 2011-05-18 MY MYPI2012004801A patent/MY160458A/en unknown
- 2011-05-18 MA MA35461A patent/MA34314B1/fr unknown
- 2011-05-18 US US13/695,785 patent/US8877817B2/en active Active
- 2011-05-18 CN CN201180024241.4A patent/CN102985069B/zh not_active Expired - Fee Related
- 2011-05-18 CA CA2799666A patent/CA2799666C/en not_active Expired - Fee Related
- 2011-05-18 AP AP2012006597A patent/AP3151A/xx active
- 2011-05-18 BR BR112012029212-9A patent/BR112012029212A2/pt not_active Application Discontinuation
- 2011-05-18 UA UAA201214331A patent/UA104381C2/uk unknown
-
2012
- 2012-10-29 TN TNP2012000516A patent/TN2012000516A1/en unknown
- 2012-11-15 ZA ZA2012/08605A patent/ZA201208605B/en unknown
-
2013
- 2013-03-04 HR HRP20130184AT patent/HRP20130184T1/hr unknown
- 2013-03-22 CY CY20131100241T patent/CY1113999T1/el unknown
- 2013-04-03 SM SM201300038T patent/SMT201300038B/xx unknown
- 2013-08-16 HK HK13109609.9A patent/HK1182315A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MA34314B1 (fr) | 2013-06-01 |
ES2403121T3 (es) | 2013-05-14 |
CN102985069B (zh) | 2014-11-26 |
UA104381C2 (uk) | 2014-01-27 |
SI2389923T1 (sl) | 2013-06-28 |
DK2389923T3 (da) | 2013-03-18 |
HRP20130184T1 (hr) | 2013-05-31 |
AP2012006597A0 (en) | 2012-12-31 |
CN102985069A (zh) | 2013-03-20 |
SMT201300038B (it) | 2013-07-09 |
PT2389923E (pt) | 2013-03-28 |
EP2389923A1 (en) | 2011-11-30 |
HK1182315A1 (en) | 2013-11-29 |
US8877817B2 (en) | 2014-11-04 |
ZA201208605B (en) | 2013-09-25 |
RU2519764C1 (ru) | 2014-06-20 |
MY160458A (en) | 2017-03-15 |
WO2011144335A1 (en) | 2011-11-24 |
TN2012000516A1 (en) | 2014-04-01 |
AP3151A (en) | 2015-03-31 |
CA2799666A1 (en) | 2011-11-24 |
EP2389923B1 (en) | 2013-01-30 |
BR112012029212A2 (pt) | 2020-09-29 |
PL2389923T3 (pl) | 2013-06-28 |
WO2011144335A8 (en) | 2012-12-06 |
US20130210922A1 (en) | 2013-08-15 |
CA2799666C (en) | 2016-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1113999T1 (el) | Σταθερο ετοιμο προς χρηση ενεσιμο σκευασμα παρακεταμολης | |
CY1122648T1 (el) | Διαδικασια για την παρασκευη συνθεσεων που περιεχουν υαλουρονικο οξυ και υδροχλωρικη μεπιβακαϊνη | |
CY1120389T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει εναν glp-1-αγωνιστη, μια ινσουλινη και μεθειονινη | |
CY1120564T1 (el) | Υδατικα εναιωρηματα tmc278 | |
CY1121041T1 (el) | Μεθοδοι αγωγης παιδιατρικων ασθενων με τη χρηση δεξμεδετομιδινης | |
CY1121150T1 (el) | Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας | |
CY1124481T1 (el) | Σταθερα χωρις συντηρητικα μυδριατικα και αντιοξειδωτικα διαλυματα για εγχυση | |
CY1119058T1 (el) | Ενωσεις ιμιδαζοπυρρολιδινονης | |
CY1119582T1 (el) | Υδατικα παρασκευασματα ινσουλινης, που περιεχουν μεθειονινη | |
CL2017002549A1 (es) | Uso de una composición de bismuto-tiol (bt), que sirve para preparar un medicamento útil para el tratamiento de una herida abierta que tiene o que está en riesgo de tener una infección de biopelícula bacteriana. | |
CY1115254T1 (el) | Φαρμακευτικα διαλυματα, διαδικασιες για την παρασκευη τους και θεραπευτικες χρησεις | |
MX2009013835A (es) | Forma de dosis estabilizada de picoplatino. | |
CY1117033T1 (el) | Αγωγη εναντι οξειας λεμφοβλαστικης λευχαιμιας | |
CY1120758T1 (el) | Σταθερα στοματικα διαλυματα για συνδυασμενα εφς | |
EP4282384A3 (en) | Stability device for use with percutaneous delivery systems | |
CY1113819T1 (el) | Σκευασματα για τη θεραπευτικη αντιμετωπιση του καρκινου | |
UA111717C2 (uk) | Склад для перорального введення і ліпофільні солі метилналтрексону | |
AR098168A1 (es) | Formulación estable de insulina glulisina | |
CY1117603T1 (el) | Η λιξισενατιδη ως προσθετο στη μετφορμινη στην θεραπευτικη αγωγη του διαβητη τυπου 2 | |
CY1117426T1 (el) | Παρεντερικη χορηγηση ταπενταδολης | |
AR087451A1 (es) | Derivado de 1,2,3,4-tetrahidroquinolina util para tratamiento de diabetes | |
EA201290833A1 (ru) | Применение амисульприда в качестве противорвотного средства | |
BR112015017251A2 (pt) | composições farmacêuticas compreendendo doadores de nitroxil | |
CY1124782T1 (el) | Φαρμακοτεχνικες μορφες μακρας δρασης | |
CY1118423T1 (el) | Σκευασματα που περιλαμβανουν την 2-αμινο-2-[2-(4-οκτυλ-φαινυλ)αιθυλ]προπανο-1,3-διολη |